Journal
NATURE REVIEWS RHEUMATOLOGY
Volume 8, Issue 12, Pages 710-718Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrrheum.2012.133
Keywords
-
Categories
Ask authors/readers for more resources
Systemic lupus erythematosus (SLE) is an autoantibody-mediated systemic autoimmune disease, predominantly affecting young females. Pregnancy is increasingly common in the setting of SLE, as survival and quality of life of patients improve. Although live births can be achieved in the most cases, pregnancy in patients with SLE remains a high-risk condition. Maternal and fetal mortality and morbidity are considerably increased, compared with the general population. Aberrations in pregnancy-related maternal immune adaptations are likely contributors. Active maternal disease, renal involvement, specific autoantibody subsets and advanced organ damage are predictors of poor outcome. Therapeutic options are limited during pregnancy as maternal benefit has to be weighed against fetal risk. Prevention of preterm birth and refractory pregnancy loss, as well as management of established neonatal heart block remain unmet needs. Further research should address these important issues that affect young patients with SLE and their babies. Lateef, A. & Petri, M. Nat. Rev. Rheumatol. 8, 710-718 (2012); published online 21 August 2012; doi:10.1038/nrrheum.2012.133
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available